Supported by: Federal Ministry of Education and Research

Company visit at GSK Marburg

Company visit at GSK Marburg

Marburg has a long history as a production site for pharmaceuticals. The first Nobel Prize winner for medicine, Emil von Behring, laid the foundation for the production of serums, vaccines and diagnostics here. The Behringwerke he founded and his healing serum against diphtheria were known far beyond the borders of Germany. Over the years, several independent companies developed from this company, which still manufacture various pharmaceutical products at the historic site. GSK - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of life to enable people to lead active, longer and healthier lives. GSK Vaccines Marburg is part of the vaccines division within the company and is divided between three sites: The main plant, Görzhausen I and the MARS Campus (Marburg site), where 1,100 employees are dedicated to helping people before they get sick. In Marburg, GSK produces vaccines, or vaccine components, against TBE, rabies, tetanus, diphtheria, pertussis and against certain meningococcal serogroups.

Event Information

Event Date 21.06.2022
Individual Price Free
Location Online

We are no longer accepting registration for this event